Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in Serum Institute of India SII

UK To Receive 10 Million Astrazeneca COVID-19 Vaccine Doses From India's Serum Institute

The UK government said the agreement follows assurances from the SII that providing doses to the UK would not impact its commitment to provide vaccines to poorer countries

Read More

UK Delegation Visits Serum Institute

'We discussed how to further enhance the existing relationship between India and the UK on manufacturing and innovation in the healthcare space.'

Read More

Serum Institute Of India Delays Vaccines For Private Sale In Bangladesh; Focus On State Campaigns

Beximco's chief operating officer told Reuters last month the company could buy up to 3 million doses of the vaccine from SII at about $8 each for sale on the private market.

Read More

Serum Institute To Stockpile Novavax Vaccine Candidate From Around April

Upwards of 40-50 million doses per month is what we are trying to stockpile starting from April

Read More

Vistara Joins COVID-19 Vaccine Transportation Drive, Carries Shipments To Various Destinations

Vistara is actively participating in transportation of COVID-19 vaccines and collaborating with the government approved suppliers

Read More

Indian Pharma Industry's COVID-19 Vaccine Plans

India, which has itself been badly hit by the pandemic with nearly 10 million infections, the second-highest in the world, is focusing on affordable vaccines instead of the expensive messenger RNA shots of Pfizer Inc and Moderna Inc.

Read More

Drug Controller Issues Show Cause Notice To SII Over Vaccine Testing

The Covid-19 vaccine search has led to a hiccup in the process where a UK participant reportedly developed reaction during the trials. Serum Institute of India responds saying it cannot comment on UK trials

Read More

DCGI sends show cause notice to Serum Institute for not pausing trial of COVID-19 vaccine

DCGI sends show cause notice to Serum Institute for not pausing trial of COVID-19 vaccine

Read More

DCGI nod to Serum-Oxford COVID19 vaccine for phase 2, 3 clinical trials in India

DCGI nod to Serum-Oxford COVID19 vaccine for phase 2, 3 clinical trials in India

Read More